|
GLG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.937000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.317100E-03 |
| Normal-vs-Stage2 |
1.590050E-01 |
| Normal-vs-Stage3 |
1.483020E-03 |
| Normal-vs-Stage4 |
2.078600E-03 |
| Stage1-vs-Stage2 |
5.511600E-01 |
| Stage1-vs-Stage3 |
3.153000E-01 |
| Stage1-vs-Stage4 |
2.029200E-01 |
| Stage2-vs-Stage3 |
2.162600E-01 |
| Stage2-vs-Stage4 |
1.897760E-01 |
| Stage3-vs-Stage4 |
7.535600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.839200E-03 |
| Normal-vs-AfricanAmerican |
4.468600E-01 |
| Normal-vs-Asian |
5.288200E-02 |
| Caucasian-vs-AfricanAmerican |
2.883800E-01 |
| Caucasian-vs-Asian |
7.847800E-01 |
| AfricanAmerican-vs-Asian |
4.137200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.478400E-02 |
| Normal-vs-Female |
2.802300E-03 |
| Male-vs-Female |
8.835000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.798400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.883590E-02 |
| Normal-vs-Age(61-80Yrs) |
1.483780E-03 |
| Normal-vs-Age(81-100Yrs) |
1.031570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.729600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.055200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.894800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.062000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.423400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.763800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.228400E-04 |
| Classical-VS-Follicular |
1.433520E-04 |
| Classical-VS-Other |
1.880230E-01 |
| Classical-VS-Normal |
7.552500E-02 |
| Tall-VS-Follicular |
8.323200E-01 |
| Tall-VS-Other |
9.590600E-01 |
| Tall-VS-Normal |
1.619080E-04 |
| Follicular-VS-Other |
8.924800E-01 |
| Follicular-VS-Normal |
1.015530E-04 |
| Other-VS-Normal |
8.573900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.844500E-03 |
| Normal-vs-N1 |
9.57480000000066E-05 |
| N0-vs-N1 |
4.001900E-02 |
|
|
